Hazel dormice: Rare rodents reintroduced in Leicestershire to boost numbers
What have wildlife experts done with the dormice?
Experts say that numbers of hazel dormice have fallen by around 70% nationally in the past twenty five years.Despite once being common across Britain, they have experienced a big drop in numbers for many reasons but particularly because of loss of habitat - places to live such as woods and hedgerows. The way woods and hedgerows are maintained has also impacted their survival as the tiny mice need dense, varied woodlands to hide and survive.According to a recent report, the species is thought to now be extinct in 20 English counties.The dormice were reintroduced this week to a secret location within the Bradgate Park Trust estate in Leicestershire by a team of experts, including wildlife charity People's Trust for Endangered Species (PTES).To help them adapt to their new environment, the animals will be first housed in open enclosures for more than a week, before being fully released into the wild.
Ian White from PTES said that the reintroduction could be an important step in starting a new population of dormice.He explained: "It's a big day for the county, as dormice haven't been seen here for a very long time."We're hopeful that by autumn, the dormice will have settled into the woodland. If we start to see litters later this year, it will mark the beginning of their return," Mr White added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
4 hours ago
- The Guardian
World's smallest snake rediscovered in Barbados 20 years after last sighting
The world's smallest snake has been rediscovered in Barbados, 20 years after its last sighting. The Barbados threadsnake, which had been feared extinct, was rediscovered under a rock in the centre of the island during an ecological survey in March by the environment ministry and the conservation organisation Re:wild. The reptile can reach up to 10cm in length when it is fully grown and is as thin as a strand of spaghetti. It had been on a global list of 4,800 plants, animals and fungi species that have been lost to science. The rarity of the snake is a concern for scientists. Connor Blades, a project officer for the environment ministry, said: 'If the threadsnake population is not very dense, I am worried about their ability to find mates, particularly if their habitat is under threat and being degraded.' Blades and Justin Springer, the Caribbean programme officer at Re:wild, had been looking for the threadsnake and several other endemic reptiles for more than a year as part of a conservation project. During the survey in March, Springer said he jokingly told Blade: 'I smell a threadsnake,' while turning over a rock trapped under a tree root. And there it was. 'When you are so accustomed to looking for things and you don't see them, you are shocked when you actually find it,' Springer said. Blades took the snake to the University of the West Indies where examination under a microscope revealed the pale orange lines running across its body and the scale on its nose that confirmed it was what they were looking for. The first sighting of the Barbados threadsnake was in 1889, and there have only been a handful of confirmed sightings since. The threadsnake reproduces sexually and the females lay only one egg at a time, unlike some other reptiles that can produce fertile eggs without mating. With 98% of the island's forest having been cleared for agriculture since it was colonised more than 500 years ago, conservationists are concerned for the reptile's extinction from habitat destruction and invasive species. 'The threadsnake's rediscovery is also a call to all of us as Barbadians that forests in Barbados are very special and need protection,' said Springer. 'Not just for the threadsnake, but for other species as well. For plants, animals and our heritage.'
The Independent
5 hours ago
- The Independent
The NHS change that could prevent 6,500 cancer cases each year
A new study suggests that thousands of breast cancer cases could be prevented annually in the UK by expanding eligibility for risk-reducing mastectomies (RRM). The research indicates that approximately 6,500 cases could be averted each year if RRM was more widely adopted beyond current genetic predispositions. Currently, RRM is primarily offered to women with BRCA1, BRCA2, or PALB2 genes, but the study proposes including those with other high-risk genes like ATM and CHEK2. The study also highlights that a combination of factors, including family history, parity, breastfeeding, and mammogram density, should be considered for RRM eligibility. Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine found RRM to be cost-effective for women aged 30-55 with a lifetime breast cancer risk of 35 per cent or more.
The Independent
5 hours ago
- The Independent
‘Risk-reducing' surgery could prevent thousands of breast cancer cases
Thousands of breast cancer cases could be averted each year if more women were offered 'risk-reducing' breast removal surgery, a new study suggests. This intervention, known as a mastectomy, is currently used to treat existing cancer or offered to those with a high genetic predisposition, specifically women carrying the BRCA1, BRCA2, or PALB2 genes. The analysis indicates that approximately 6,500 cases of breast cancer could be prevented annually if preventative mastectomies were more widely adopted. Crucially, the research proposes expanding eligibility beyond the currently recognised genetic markers. Women with other genes linked to increased risk, such as ATM, CHEK2, RAD51C, and RAD51D, may also benefit. Furthermore, the study highlights that a combination of other factors, including a family history of breast cancer, parity (number of children), breastfeeding history, and mammogram density, should be considered in assessing a woman's overall high risk for the disease, potentially making them candidates for risk-reducing mastectomies. Women in the UK have an 11 per cent chance of developing breast cancer across their lifetime. Medics can calculate a woman's risk of breast cancer using tools which combine the effect of various risk factors. Researchers from Queen Mary University of London and the London School of Hygiene and Tropical Medicine (LSHTM) found that if health officials could identify all women aged 30 to 55 who have a 35 per cent or higher risk of breast cancer, and they all went on to have RRM, then an estimated 6,538 breast cancer cases could be prevented in the UK each year. This is the equivalent of around 11 per cent of the 59,000 women in the UK who are diagnosed with breast cancer each year. The academics point out that women who have one of the other genes linked to breast cancer, who may be at high risk of disease, could potentially be found by a mechanism called 'cascade testing' – where genetic tests are offered to family members of women who have been found to have these different genes linked to breast cancer. The economic evaluation study, published in the journal JAMA Oncology, concludes: 'Undergoing RRM appears cost-effective for women at 30-55 years with a lifetime BC-risk 35 per cent (or more). 'The results could have significant clinical implications to expand access to RRM beyond BRCA1/BRCA2/PALB2 pathogenic variant carriers.' Corresponding author on the paper, Professor Ranjit Manchanda, professor of gynaecological oncology at Queen Mary and consultant gynaecological oncologist, said: 'We for the first time define the risk at which we should offer RRM. 'Our results could have significant clinical implications to expand access to mastectomy beyond those patients with known genetic susceptibility in high penetrance genes- BRCA1/ BRCA2/ PALB2 – who are traditionally offered this. 'This could potentially prevent can potentially prevent (around) 6500 breast cancer cases annually in UK women. 'We recommend that more research is carried out to evaluate the acceptability, uptake, and long-term outcomes of RRM among this group'. Dr Rosa Legood, associate professor in health economics at LSHTM, added: 'Undergoing RRM is cost-effective for women (aged) 30 to 55-years with a lifetime breast cancer risk of 35 per cent or more. 'These results can support additional management options for personalised breast cancer risk prediction enabling more women at increased risk to access prevention.' Women deemed to be at high risk of breast cancer can also be offered regular screening and medication. Louise Grimsdell, Breast Cancer Now senior clinical nurse specialist, said: 'While this modelling provides valuable insights into the cost-effectiveness of risk-reducing mastectomy for women with a high risk of developing breast cancer, each individual must be offered all risk-management options that are suitable for them. 'Choosing to have risk-reducing surgery is a complex and deeply personal decision that comes with emotional and physical implications. 'So, it's vital women can consider all their options, including screening and risk-reducing medications, and are supported by their clinician to make an informed decision that's right for them. 'It's also crucial that the unacceptably long waits that far too many women who chose risk-reducing surgery are facing are urgently tackled.'
